Movatterモバイル変換


[0]ホーム

URL:


FR7428M - - Google Patents

Info

Publication number
FR7428M
FR7428MFR79000485AFR79000485AFR7428MFR 7428 MFR7428 MFR 7428MFR 79000485 AFR79000485 AFR 79000485AFR 79000485 AFR79000485 AFR 79000485AFR 7428 MFR7428 MFR 7428M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR79000485A
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to FR79000485ApriorityCriticalpatent/FR7428M/fr
Application grantedgrantedCritical
Publication of FR7428MpublicationCriticalpatent/FR7428M/fr
Expiredlegal-statusCriticalCurrent

Links

Classifications

Landscapes

FR79000485A1968-05-061968-05-06ExpiredFR7428M (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
FR79000485AFR7428M (en)1968-05-061968-05-06

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
FR79000485AFR7428M (en)1968-05-061968-05-06

Publications (1)

Publication NumberPublication Date
FR7428Mtrue FR7428M (en)1969-11-12

Family

ID=9696341

Family Applications (1)

Application NumberTitlePriority DateFiling Date
FR79000485AExpiredFR7428M (en)1968-05-061968-05-06

Country Status (1)

CountryLink
FR (1)FR7428M (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
WO2000026203A1 (en)*1998-10-302000-05-11Pharmacia & Upjohn S.P.A.2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
US7125888B2 (en)2002-05-022006-10-24Merck & Co., Inc.Tyrosine kinase inhibitors
WO2007006814A1 (en)*2005-07-142007-01-18Novo Nordisk A/SUrea glucokinase activators
US7265134B2 (en)2001-08-172007-09-04Merck & Co., Inc.Tyrosine kinase inhibitors
US7598391B2 (en)2004-01-062009-10-06Novo Nordisk A/SHeteroaryl-ureas and their use as glucokinase activators
US7897628B2 (en)2002-06-272011-03-01Novo Nordisk A/SAryl carbonyl derivatives as therapeutic agents
US7999114B2 (en)2005-07-082011-08-16Novo Nordisk A/SDicycloalkylcarbamoyl ureas as glucokinase activators
US8138185B2 (en)2007-01-092012-03-20Novo Nordisk A/SUrea glucokinase activators
US8318778B2 (en)2007-01-112012-11-27Novo Nordisk A/SUrea glucokinase activators
US11833136B2 (en)2018-06-122023-12-05Vtv Therapeutics LlcTherapeutic uses of glucokinase activators in combination with insulin or insulin analogs
US12391658B2 (en)2020-02-182025-08-19Vtv Therapeutics LlcSulfoxide and sulfone glucokinase activators and methods of use thereof

Cited By (19)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
WO2000026203A1 (en)*1998-10-302000-05-11Pharmacia & Upjohn S.P.A.2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
US7265134B2 (en)2001-08-172007-09-04Merck & Co., Inc.Tyrosine kinase inhibitors
US7125888B2 (en)2002-05-022006-10-24Merck & Co., Inc.Tyrosine kinase inhibitors
US8063081B2 (en)2002-06-272011-11-22Novo Nordisk A/SAryl carbonyl derivatives as therapeutic agents
US7897628B2 (en)2002-06-272011-03-01Novo Nordisk A/SAryl carbonyl derivatives as therapeutic agents
USRE45183E1 (en)2004-01-062014-10-07Novo Nordisk A/SHeteroaryl-ureas and their use as glucokinase activators
US7598391B2 (en)2004-01-062009-10-06Novo Nordisk A/SHeteroaryl-ureas and their use as glucokinase activators
US7872139B2 (en)2004-01-062011-01-18Novo Nordisk A/SHeteroaryl-ureas and their use as glucokinase activators
US7999114B2 (en)2005-07-082011-08-16Novo Nordisk A/SDicycloalkylcarbamoyl ureas as glucokinase activators
US7884210B2 (en)2005-07-142011-02-08Novo Nordisk A/SUreido-thiazole glucokinase activators
RU2443691C2 (en)*2005-07-142012-02-27Транстех Фарма, Инк.Urea glucokinase activators
US8586614B2 (en)2005-07-142013-11-19Novo Nordisk A/SUrea glucokinase activators
WO2007006814A1 (en)*2005-07-142007-01-18Novo Nordisk A/SUrea glucokinase activators
US8138185B2 (en)2007-01-092012-03-20Novo Nordisk A/SUrea glucokinase activators
US8318778B2 (en)2007-01-112012-11-27Novo Nordisk A/SUrea glucokinase activators
US8362049B2 (en)2007-01-112013-01-29Novo Nordisk A/SUrea glucokinase activators
US11833136B2 (en)2018-06-122023-12-05Vtv Therapeutics LlcTherapeutic uses of glucokinase activators in combination with insulin or insulin analogs
US11974989B2 (en)2018-06-122024-05-07Vtv Therapeutics LlcTherapeutic uses of glucokinase activators in combination with insulin or insulin analogs
US12391658B2 (en)2020-02-182025-08-19Vtv Therapeutics LlcSulfoxide and sulfone glucokinase activators and methods of use thereof

Similar Documents

PublicationPublication DateTitle
AU1946070A (en)
AU428130B2 (en)
AU2374870A (en)
AU5184069A (en)
AU6168869A (en)
AU6171569A (en)
AU416157B2 (en)
AU429879B2 (en)
AU2581067A (en)
AU4811568A (en)
AU421558B1 (en)
AU3789668A (en)
AU3224368A (en)
AU4744468A (en)
AU2580267A (en)
AU4224469A (en)
BE708888A (en)
BE709301A (en)
AU4503667A (en)
AU479393A (en)
AU479894A (en)
AU4464266A (en)
AU4270368A (en)
BE709320A (en)
AU5758767A (en)

Legal Events

DateCodeTitleDescription
STNotification of lapse

[8]ページ先頭

©2009-2025 Movatter.jp